Target
Carbonic anhydrase 13
Ligand
BDBM50163863
Substrate
n/a
Meas. Tech.
ChEMBL_1673903 (CHEMBL4023932)
Kd
0.19±n/a nM
Citation
 Linkuvien?, VTalibov, VODanielson, UHMatulis, D Introduction of Intrinsic Kinetics of Protein-Ligand Interactions and Their Implications for Drug Design. J Med Chem 61:2292-2302 (2018) [PubMed]  Article 
Target
Name:
Carbonic anhydrase 13
Synonyms:
CA13 | CAH13_HUMAN | Carbonic anhydrase | Carbonic anhydrase 13 (CA XIII) | Carbonic anhydrase XIII (CA XIII)
Type:
Enzyme
Mol. Mass.:
29445.78
Organism:
Homo sapiens (Human)
Description:
Q8N1Q1
Residue:
262
Sequence:
MSRLSWGYREHNGPIHWKEFFPIADGDQQSPIEIKTKEVKYDSSLRPLSIKYDPSSAKIISNSGHSFNVDFDDTENKSVLRGGPLTGSYRLRQVHLHWGSADDHGSEHIVDGVSYAAELHVVHWNSDKYPSFVEAAHEPDGLAVLGVFLQIGEPNSQLQKITDTLDSIKEKGKQTRFTNFDLLSLLPPSWDYWTYPGSLTVPPLLESVTWIVLKQPINISSQQLAKFRSLLCTAEGEAAAFLVSNHRPPQPLKGRKVRASFH
  
Inhibitor
Name:
BDBM50163863
Synonyms:
4-(1H-benzimidazol-1-ylacetyl)-2-chlorobenzenesulfonamide (2a) | CHEMBL3798446 | carbonic anhydrase (CA) inhibitors, benzenesulphonamide ligand, 2
Type:
Small organic molecule
Emp. Form.:
C15H12ClN3O3S
Mol. Mass.:
349.792
SMILES:
NS(=O)(=O)c1ccc(cc1Cl)C(=O)Cn1cnc2ccccc12
Structure:
Search PDB for entries with ligand similarity: